OBJECTIVE: To evaluate HLA-DRB1 genetic risk of rheumatoid arthritis (RA) in African Americans by 3 validated allele classification systems and by amino acid position and residue, and to compare genetic risk between African American and European ancestries. METHODS: Four-digit HLA-DRB1 genotyping was performed on 561 autoantibody-positive African American cases and 776 African American controls. Association analysis was performed on Tezenas du Montcel (TdM), de Vries (DV), and Mattey classification system alleles and separately by amino acid position and individual residues. RESULTS: TdM S2 and S3P alleles were associated with RA (odds ratio [95% confidence interval] 2.8 [2.0-3.9] and 2.1 [1.7-2.7], respectively). The DV (P = 3.2 × 10(-12)) and Mattey (P = 6.5 × 10(-13)) system alleles were both protective in African Americans. Amino acid position 11 (permutation P < 0.00001) accounted for nearly all variability explained by HLA-DRB1, although conditional analysis demonstrated that position 57 was also significant (0.01 ≤ permutation P ≤ 0.05). The valine and aspartic acid residues at position 11 conferred the highest risk of RA in African Americans. CONCLUSION: With some exceptions, the genetic risk conferred by HLA-DRB1 in African Americans is similar to that in individuals of European ancestry at multiple levels: classification system (e.g., TdM), amino acid position (e.g., 11), and residue (Val11). Unlike that reported for individuals of European ancestry, amino acid position 57 was associated with RA in African Americans, but positions 71 and 74 were not. Asp11 (odds ratio 1 in European ancestry) corresponds to the 4-digit classical allele *09:01, which is also a risk allele for RA in Koreans.
OBJECTIVE: To evaluate HLA-DRB1 genetic risk of rheumatoid arthritis (RA) in African Americans by 3 validated allele classification systems and by amino acid position and residue, and to compare genetic risk between African American and European ancestries. METHODS: Four-digit HLA-DRB1 genotyping was performed on 561 autoantibody-positive African American cases and 776 African American controls. Association analysis was performed on Tezenas du Montcel (TdM), de Vries (DV), and Mattey classification system alleles and separately by amino acid position and individual residues. RESULTS: TdM S2 and S3P alleles were associated with RA (odds ratio [95% confidence interval] 2.8 [2.0-3.9] and 2.1 [1.7-2.7], respectively). The DV (P = 3.2 × 10(-12)) and Mattey (P = 6.5 × 10(-13)) system alleles were both protective in African Americans. Amino acid position 11 (permutation P < 0.00001) accounted for nearly all variability explained by HLA-DRB1, although conditional analysis demonstrated that position 57 was also significant (0.01 ≤ permutation P ≤ 0.05). The valine and aspartic acid residues at position 11 conferred the highest risk of RA in African Americans. CONCLUSION: With some exceptions, the genetic risk conferred by HLA-DRB1 in African Americans is similar to that in individuals of European ancestry at multiple levels: classification system (e.g., TdM), amino acid position (e.g., 11), and residue (Val11). Unlike that reported for individuals of European ancestry, amino acid position 57 was associated with RA in African Americans, but positions 71 and 74 were not. Asp11 (odds ratio 1 in European ancestry) corresponds to the 4-digit classical allele *09:01, which is also a risk allele for RA in Koreans.
Authors: Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler Journal: Science Date: 2002-05-23 Impact factor: 47.728
Authors: Yael Baran; Bogdan Pasaniuc; Sriram Sankararaman; Dara G Torgerson; Christopher Gignoux; Celeste Eng; William Rodriguez-Cintron; Rocio Chapela; Jean G Ford; Pedro C Avila; Jose Rodriguez-Santana; Esteban Gonzàlez Burchard; Eran Halperin Journal: Bioinformatics Date: 2012-04-11 Impact factor: 6.937
Authors: D L Mattey; P T Dawes; M A Gonzalez-Gay; C Garcia-Porrua; W Thomson; A H Hajeer; W E Ollier Journal: J Rheumatol Date: 2001-02 Impact factor: 4.666
Authors: M Molokhia; C Hoggart; A L Patrick; M Shriver; E Parra; J Ye; A J Silman; P M McKeigue Journal: Hum Genet Date: 2003-01-24 Impact factor: 4.132
Authors: S L Bridges; L B Hughes; T R Mikuls; G Howard; H K Tiwari; G S Alarcón; J M McNicholl; L W Moreland Journal: Clin Exp Rheumatol Date: 2003 Sep-Oct Impact factor: 4.473
Authors: Eli A Stahl; Daniel Wegmann; Gosia Trynka; Javier Gutierrez-Achury; Ron Do; Benjamin F Voight; Peter Kraft; Robert Chen; Henrik J Kallberg; Fina A S Kurreeman; Sekar Kathiresan; Cisca Wijmenga; Peter K Gregersen; Lars Alfredsson; Katherine A Siminovitch; Jane Worthington; Paul I W de Bakker; Soumya Raychaudhuri; Robert M Plenge Journal: Nat Genet Date: 2012-03-25 Impact factor: 38.330
Authors: Maria I Danila; Vincent Albert Laufer; Richard J Reynolds; Qi Yan; Nianjun Liu; Peter K Gregersen; Annette Lee; Marlena Kern; Carl D Langefeld; Donna K Arnett; S Louis Bridges Journal: Mol Med Date: 2017-06-29 Impact factor: 6.354
Authors: Vincent A Laufer; Hemant K Tiwari; Richard J Reynolds; Maria I Danila; Jelai Wang; Jeffrey C Edberg; Robert P Kimberly; Leah C Kottyan; John B Harley; Ted R Mikuls; Peter K Gregersen; Devin M Absher; Carl D Langefeld; Donna K Arnett; S Louis Bridges Journal: Hum Mol Genet Date: 2019-03-01 Impact factor: 6.150
Authors: Iris Navarro-Millán; Erika Darrah; Andrew O Westfall; Ted R Mikuls; Richard J Reynolds; Maria I Danila; Jeffrey R Curtis; Antony Rosen; S Louis Bridges Journal: Arthritis Res Ther Date: 2016-10-22 Impact factor: 5.156
Authors: Sytske Anne Bergstra; Arvind Chopra; Manjit Saluja; David Vega-Morales; Nimmisha Govind; Tom W J Huizinga; Annette van der Helm-van Mil Journal: RMD Open Date: 2017-12-10